Alexandria Real Estate Equities (ARE)

Stock price history of Alexandria Real Estate Equities from 1997 to 2026

Annual Stock Price Performance

Year	Performance
2026	9.83%
2025	-48.17%
2024	-21.02%
2023	-8.13%
2022	-31.67%
2021	33.68%
2020	14.58%
2019	49.05%
2018	-8.51%
2017	21.55%
2016	28.74%
2015	4.07%
2014	44.53%
2013	-6.26%
2012	3.74%
2011	-4.95%
2010	17.78%
2009	14.59%
2008	-39.15%
2007	3.94%
2006	25.66%
2005	14.40%
2004	34.04%
2003	43.69%
2002	8.99%
2001	16.50%
2000	23.76%
1999	8.24%
1998	3.23%
1997	50.00%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Pfizer PFE	22,97 €	1.54%	🇺🇸 USA
Eli Lilly LLY	898,40 €	4.86%	🇺🇸 USA
Amgen AMGN	322,01 €	1.25%	🇺🇸 USA
Gilead Sciences GILD	127,16 €	-1.04%	🇺🇸 USA
Illumina ILMN	102,30 €	2.44%	🇺🇸 USA
Bristol-Myers Squibb BMY	51,98 €	0.97%	🇺🇸 USA
Alnylam Pharmaceuticals ALNY	279,52 €	-2.03%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Alexandria Real Estate Equities (ARE)